Acta Otolaryngol. 2025 May 17:1-7. doi: 10.1080/00016489.2025.2504032. Online ahead of print.
ABSTRACT
BACKGROUND: Single-sided deafness (SSD) encompasses the presence of a profoundly deaf ear with a normal, contralateral one. Patients with SSD may have difficulty with speech intelligibility in noise and localizing sounds.
AIMS/OBJECTIVES: This retrospective study aims to evaluate the long-term effectiveness of bone conduction implant (BCI) in a group of patients with SSD.
MATERIAL AND METHODS: Audiologic benefit was assessed through conventional speech audiometry and adaptive Matrix test. Impact on quality of life was evaluated with the Glasgow Benefit Inventory (GBI) questionnaire. BCI usage data were also obtained from each subject.
RESULTS: Thirty-two patients were included. No statistically significant improvements were found at standard audiometric tests using BCI, but at Matrix test the mean SRT is reached at S/N -1.16 dB without BCI and -2.07 with BCI with a statistically significant difference (p = 0.026). The mean GBI score was 25.12, ranging from -8.3 to 47.2. Ten subjects (31%) discontinued the BCI use overtime.
CONCLUSIONS AND SIGNIFICANCE: Benefit assessment of BCI in SSD recipients can be difficult. Adaptive audiometric test could be useful. Quality of life measures seem to suggest potential ‘beyond-auditory’ benefits. SSD recipients can be inconsistent users of BCI.
PMID:40382679 | DOI:10.1080/00016489.2025.2504032
